LORENA TORRES: Open Payments
NPI 1013315167 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,037 in 142 payments from 18 companies in 2025. Trend: 2023 $1,510 · 2024 $2,890 · 2025 $3,037
Food & beverage: $3,037
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 36 | $928 |
| ViiV Healthcare Company | 34 | $708 |
| Kowa Pharmaceuticals America, Inc. | 35 | $256 |
| Novo Nordisk Inc | 6 | $230 |
| SHIELD THERAPEUTICS INC | 3 | $160 |
| Madrigal Pharmaceuticals | 1 | $134 |
| Theratechnologies Inc. | 4 | $99 |
| Merck Sharp & Dohme LLC | 5 | $93 |
| Almatica Pharma LLC | 4 | $91 |
| EMD Serono, Inc. | 2 | $72 |
Products named: CABENUVA, DOVATO, ZORYVE, ACCRUFER, Biktarvy, REZDIFFRA, Yeztugo, Wegovy.
Industry payments across CA — which companies pay providers there.
